BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12419431)

  • 1. The importance of radiation doses to the penile bulb vs. crura in the development of postbrachytherapy erectile dysfunction.
    Merrick GS; Butler WM; Wallner KE; Lief JH; Anderson RL; Smeiles BJ; Galbreath RW; Benson ML
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(4):1055-62. PubMed ID: 12419431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction.
    Merrick GS; Wallner K; Butler WM; Galbreath RW; Lief JH; Benson ML
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):597-604. PubMed ID: 11395225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erectile function after prostate brachytherapy.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Anderson RL; Kurko BS; Lief JH; Allen ZA
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):437-47. PubMed ID: 15890585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erectile function after permanent prostate brachytherapy.
    Merrick GS; Butler WM; Galbreath RW; Stipetich RL; Abel LJ; Lief JH
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):893-902. PubMed ID: 11958881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dosimetry of brachytherapy-induced erectile dysfunction.
    Merrick GS; Butler WM
    Med Dosim; 2003; 28(4):271-4. PubMed ID: 14684193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation dose to the neurovascular bundles or penile bulb does not predict erectile dysfunction after prostate brachytherapy.
    Kiteley RA; Lee WR; deGuzman AF; Mirzaei M; McCullough DL
    Brachytherapy; 2002; 1(2):90-4. PubMed ID: 15062176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapy.
    Solan AN; Cesaretti JA; Stone NN; Stock RG
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1468-74. PubMed ID: 18922652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of radiation dose to the neurovascular bundles in men with and without prostate brachytherapy-induced erectile dysfunction.
    Merrick GS; Butler WM; Dorsey AT; Lief JH; Donzella JG
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1069-74. PubMed ID: 11072164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for erectile dysfunction in men with prostate cancer after brachytherapy: is dose to the penile bulb important?
    Macdonald AG; Keyes M; Kruk A; Duncan G; Moravan V; Morris WJ
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):155-63. PubMed ID: 16111584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397).
    Mangar SA; Sydes MR; Tucker HL; Coffey J; Sohaib SA; Gianolini S; Webb S; Khoo VS; ; Dearnaley DP
    Radiother Oncol; 2006 Sep; 80(3):355-62. PubMed ID: 16949694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of neurovascular bundles on pelvic CT and evaluation of radiation dose to structures putatively involved in erectile dysfunction after prostate brachytherapy.
    Wright JL; Newhouse JH; Laguna JL; Vecchio D; Ennis RD
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):426-35. PubMed ID: 15145159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose to the penile bulb and individual patient anatomy are predictive of erectile dysfunction in men treated with
    Chasseray M; Dissaux G; Bourbonne V; Boussion N; Goasduff G; Malloreau J; Malhaire JP; Fournier G; Tissot V; Pradier O; Valeri A; Schick U
    Acta Oncol; 2019 Jul; 58(7):1029-1035. PubMed ID: 30761939
    [No Abstract]   [Full Text] [Related]  

  • 13. Erectile dysfunction and radiation dose to penile base structures: a lack of correlation.
    Selek U; Cheung R; Lii M; Allen P; Steadham RE; Vantreese TR; Little DJ; Rosen II; Kuban D
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1039-46. PubMed ID: 15234037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erectile function durability following permanent prostate brachytherapy.
    Taira AV; Merrick GS; Galbreath RW; Butler WM; Wallner KE; Kurko BS; Anderson R; Lief JH
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):639-48. PubMed ID: 19303721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer.
    Wernicke AG; Valicenti R; Dieva K; Houser C; Pequignot E
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1357-63. PubMed ID: 15590165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-volume parameters of the corpora cavernosa do not correlate with erectile dysfunction after external beam radiotherapy for prostate cancer: results from a dose-escalation trial.
    van der Wielen GJ; Hoogeman MS; Dohle GR; van Putten WL; Incrocci L
    Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):795-800. PubMed ID: 18164862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced radiation tolerance of penile structures associated with dose-escalated hypofractionated prostate radiotherapy.
    McDonald AM; Baker CB; Shekar K; Popple RA; Clark GM; Yang ES; Jacob R; Kim RY; Fiveash JB
    Urology; 2014 Dec; 84(6):1383-7. PubMed ID: 25440987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel prostate brachytherapy technique: improved dosimetric and clinical outcome.
    Nobes JP; Khaksar SJ; Hawkins MA; Cunningham MJ; Langley SE; Laing RW
    Radiother Oncol; 2008 Jul; 88(1):121-6. PubMed ID: 18499289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of erectile function after intensity modulated radiation therapy for localized prostate carcinoma.
    Brown MW; Brooks JP; Albert PS; Poggi MM
    Prostate Cancer Prostatic Dis; 2007; 10(2):189-93. PubMed ID: 17189954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexual function and the use of medical devices or drugs to optimize potency after prostate brachytherapy.
    Whaley JT; Levy LB; Swanson DA; Pugh TJ; Kudchadker RJ; Bruno TL; Frank SJ
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e765-71. PubMed ID: 22300559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.